Lindner Center of HOPE

Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes management and later expanded to obesity treatment, have shown preliminary efficacy in reducing binge eating episodes. However, the appetite-suppressing and weight-loss effects of GLP-1R...

Spinal interoceptive pathways as therapeutic targets in depression

Interoception is commonly defined as the process by which the nervous system senses, interprets and integrates signals from the body. Converging theoretical frameworks propose that signals about bodily states are conveyed by spinal interoceptive pathways (SIPs) to a distributed i...